MyoKardia goes public well below targets, IPO raises $54M
October 29, 2015 at 10:12 AM EDT
South San Francisco heart drug developer MyoKardia Inc. is the second Bay Area company this week to price its IPO well below targets, raising $54 million in an offering that priced on Wednesday...
